Join
Live feed
·
INSIDERFilingvia Quantisnow
Evelo Biosciences Inc. logo

Thorell Marella converted options into 12,500 shares and sold $1,320 worth of shares (3,999 units at $0.33), increasing direct ownership by 94% to 17,570 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EVLO (Evelo Biosciences Inc.) and more on Quantisnow.